NFKB1 and cancer: Studies have confirmed that NF-κB is a transcription factor with oncologic therapeutic potential and has been recognized for its important role in colorectal cancer (Plewka et al., 2018), gynecologic cancers (Harrington and Annunziata., 2019; Diéguez-Martinez et al., 2022), pancreatic cancer (Geismann et al., 2019), and other types of cancer.